The economic rationale for adherence in the treatment of type 2 diabetes mellitus.

  • Howard Wild
  • Published 2012 in The American journal of managed care
Among patients with type 2 diabetes mellitus, adherence to prescribed medications has been reported to be as low as 60%, meaning that many patients may not be following the treatment plan that has been prescribed for them. The importance of treatment adherence is intuitive: better adherence would promote better outcomes. Data show this to be the case: for… CONTINUE READING